EPIX Pharma (EPIX) Reports Mixed Q1 Results
EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) reports Q1 loss of $0.23, 1 cent lower than the analyst estimate of ($0.22). Revenue for the quarter was $3.7 million, versus the consensus of $2.90 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
